Although the qac genes are named after one of their main substrates (i.e., quaternary ammonium compounds), these genes also code for resistance to a broad spectrum of other cationic compounds such as intercalating dyes, diamidines and biguanides. The various Qac proteins are involved in relatively low specific effluxbased multidrug pumps and belong to a family of small multidrug resistance proteins. Even though the practical significance of qac-mediated resistance lies mainly in resistance to antiseptics, contradictory findings on this issue are still reported. Therefore, the aim of this review is to summarise the current knowledge on qac-mediated resistance with special emphasis on resistance to antiseptics and its relevance for practice.
Introduction
Resistance to intercalating dyes (i.e. acriflavine and ethidium) was associated with particular genetic elements, namely staphylococcal β-lactamase plasmids, already more than 40 years ago (Ericson 1969; Johnston and Dyke 1969) . Thereafter, various Staphylococcus aureus aminoglycoside-resistance plasmids were linked with resistance to quaternary ammonium compounds (QACs) and ethidium bromide (i.e. Archer and Johnston 1983; McDonnell et al. 1983) . Furthermore, the commonly detected S. aureus plasmid pSK1 coding for resistance to aminoglycosides and trimethoprim was also found to encode resistance to intercalating dyes, QACs and diamidines (Lyon et al. 1984; Gillespie et al. 1986; Lyon and Skurray 1987) . The first described genetic determinant of resistance to antiseptics was the qacA gene found on pSK1 and β-lactamase/heavy metal resistance plasmids (Gillespie et al. 1986; Lyon and Skurray 1987) . A range of other qac genes linked with particular plasmids (Littlejohn et al. 1992) were further reported as summarised below.
1. Introduction 2. The qac genes and their distribution 3. Qac-mediated resistance 3.1. Mechanisms of qac-mediated resistance 3.2. Substrates of qac-mediated resistance 3.3. Adaptive response to antiseptics 4. The qac genes and resistance to antibiotics 5. Conclusions 6. References dicted to have evolved from qacD (Littlejohn et al. 1991) . These two genes are now usually reported as smr (Bischoff et al. 2012) . A high degree of similarity between another two qac genes (qacE and qacF) was shown by Ploy et al. (1998) . The remaining qac genes include qacG (Heir et al. 1999) , qacH (Heir et al. 1998) , qacJ (Bjorland et al. 2003) and qacZ (Braga et al. 2011) .
Although the qac genes are widely spread among clinical and environmental bacteria, it is obvious that their distribution is generally linked with a particular bacterial species. Among Gram-positive bacteria, the qac genes clearly predominate in staphylococci, in which the qacA/B genes were most frequently reported followed by the qacC/D genes (e.g. Longtin et al. 2011; Zmantar et al. 2012) . Other qac genes, such as qacG, qacH and qacJ, have been less frequently observed (Ye et al. 2012) . Besides staphylococci, the qac genes were also detected in enterococci. For instance, the qacA/B genes (which are highly prevalent in staphylococci) and the most recently identified qac gene, qacZ, were recently found in Enterococcus faecalis (Braga et al. 2011; Bischoff et al. 2012) .
On the other hand, the qacE gene (including its attenuated variant qacEΔ1) is widely spread in Gramnegative bacteria, mainly in Enterobacteriaceae and Pseudomonas spp. but also in a range of other species such as Aeromonas spp., Vibrio spp., Acinetobacter spp. or those belonging to Xanthomonadaceae and Helicobacteraceae (Kazama et al. 1998; Chang et al. 2007; Wang et al. 2008a; Mak et al. 2009 ). This is mainly due to the high prevalence of class 1 integrons, which in Gram-negative bacteria commonly comprise qacEΔ1 (Kazama et al. 1998; Bass et al. 1999; Rosser and Young 1999) . Nevertheless, Kazama et al. (1998) reported that qacEΔ1 may occur in Gram-positive cocci as well. Although less frequently, other qac genes were also found in Gram-negative bacteria. The qacH gene was most often described in Enterobacteriaceae (Soufi et al. 2009; Wannaprasat et al. 2011 ) whereas other qac genes (e.g. qacF) were reported only sporadically (Borgianni et al. 2011). 3. Qac-mediated resistance
Mechanisms of qac-mediated resistance
The involvement of an efflux-based system in qac-mediated resistance was first observed for the qacA and qacE genes (Jones and Midgley 1985; Tennent et al. 1989 ). In accordance with that, an energy-dependent efflux pump relying on the proton motive force was later confirmed as a mechanism of resistance conferred by the qac genes (Rouch et al. 1990; Littlejohn et al. 1992) . Rouch et al. (1990) also demonstrated that qac-mediated efflux-based resistance has a common ancestry with tetracycline and sugar transport proteins. Further analysis of the Qac proteins revealed that these belong to a small multidrug resistance (SMR) protein family integrated in the cytoplasmic membrane via transmembrane segments and containing distinct subsets of amino acid residues involved in substrate recognition and binding (Rouch et al. 1990; Paulsen et al. 1995; Brown and Skurray 2001) .
The Qac pumps are regulated via the transacting repressor protein QacR, which was shown to overlap with the promoter sequence for qacA. A range of diverse cationic lipophilic compounds are able to dissociate QacR from the operator DNA via its multidrug-binding pocket (Brown and Skurray 2001; Grkovic et al. 2003) .
Substrates of qac-mediated resistance
Although the qac genes are named after one of their main substrates (QACs), the spectrum of their activity is much wider. qac-mediated resistance targets more than 30 lipophilic cationic compounds belonging to at least 12 different chemical classes (Hassan et al. 2006) . Overall, substrates of the qac genes comprise various monovalent and divalent cationic compounds. For example, monovalent cations consist of intercalating dyes (e.g. acriflavine, ethidium, crystal violet) and the majority of QACs (e.g., benzalkonium, cetylpyridinum, cetrimide). Divalent cations include biguanidines (e.g., chlorhexidine), diamidines (e.g., propamidine, hexamidine, pentamidine), guanylhydrazones and some QACs (e.g., deqaulinium; Tennent et al. 1989; Littlejohn et al. 1992; Mitchell et al. 1998; Brown and Skurray 2001 ). An interesting finding was reported by Bayer et al. (2006) , who demonstrated that the qacA gene confers resistance to thrombin-induced platelet microbial protein 1, a cationic antimicrobial polypeptide released from thrombin-stimulated rabbit platelets.
The epidemiological and clinical significance of qac-mediated resistance is mainly attributed to resistance to antiseptics. In the first instance, the qac genes have been considered as important genetic determinants of resistance to QACs and, therefore, have been monitored by many authors (e.g., Bjorland et al. 2005 ). However, their practical relevance in conferring resistance to QACs is highly questionable. Little or no increase in resistance to QACs in bacteria of various species carrying qac genes has been reported by several authors. It was shown in both Gram-positive and Gram-negative bacteria that minimum inhibitory concentrations of several QAC agents were comparable between different isolates regardless of the presence of qac genes (Kucken et al. 2000; Jaglic et al. 2012 ). In S. aureus, Smith et al. (2008) reported that differences in bactericidal concentrations of QACs between qac-positive and qac-negative isolates were statistically significant but lower than twofold. Furthermore, no overexpression among the qac genes was observed in S. aureus exposed to various QAC agents (DeMarco et al. 2007 ). In Pseudomonas aeruginosa, Romao et al. (2011) demonstrated that the qacEΔ1 gene does not play an important role in resistance to benzalkonium chloride (BAC), a member of QACs. One explanation for this could lie in the fact that qac-mediated resistance is targeted to a broad spectrum of distinct cationic compounds resulting in the exclusion of a high-level specificity to QACs (Grkovic et al. 2003; Bay and Turner 2009 ). Moreover, qac-mediated resistance could be affected by the specific conditions, under which bacterial cells are exposed to the qac substrates. For example, it was reported that non-specific chemical and physical stressors may induce qacA transcription (Galluzzi et al. 2003) .
On the other hand, there is a range of other studies reporting on a close association between the increased resistance to various cationic compounds and the presence of the qac genes. A high-level resistance to diamidines together with increased resistance to intercalating dyes, QACs and biguanidines was described in staphylococci carrying the qacA and/or qacC genes (Leelaporn et al. 1994) . A high correlation between the presence of qacA and resistance to BAC, hexamidine, chlorhexidine, acriflavine and ethidium bromide was observed in S. aureus (Behr et al. 1994) . Heir et al. (1995) reported that 80% of QAC-resistant staphylococci harboured qac genes. Similarly, a high prevalence of qacA/B in isolates showing increased minimum inhibitory concentrations of acriflavine, QACs and chlorhexidine was demonstrated by Noguchi et al. (2005) . In another study, the qacA/B gene was found in 94.6% of QAC-tolerant S. aureus isolates (Liu et al. 2009 ). Moreover, recently, the qac genes have been increasingly associated with resistance to chlorhexidine (Smith et al. 2008; Wang et al. 2008b; Sheng et al. 2009 ). Based on the aforementioned findings, it could be generally assumed that the qac genes may increase resistance to various cationic antiseptics. However, their practical relevance is disputable because the commonly used concentrations (recommended by the manufacturer) of such antiseptics are usually higher than those tolerated due to action of the qac genes (Smith et al. 2008 ).
Adaptive response to antiseptics
It should be further mentioned that the qac genes may play an important role in adaption to various cationic compounds. A stepwise adaption to twofold increasing concentrations of QACs was recently described in S. aureus carrying the qac genes (Smith et al. 2008) . Sundheim et al. (1998) formerly observed that although resistance to QACs is generally low among qac-positive staphylococci, resistant strains were isolated after exposure to a QAC disinfectant. Furthermore, Heir et al. (1999) showed that under the pressure of sublethal concentrations of BAC, qacG-harbouring staphylococci adapted to this antiseptic. Similarly, increased post-exposure resistance to chlorhexidine was observed in S. aureus carrying the qac genes (Vali et al. 2008) .
However, adaption to BAC, chlorhexidine and some other antiseptics was also described in staphylococci negative for the qac genes (Heir et al. 1999; Vali et al. 2008) . Therefore, the question as to whether the adaption to cationic compounds is driven by the qac genes or rather by other mechanisms remains open. Modifications in the cell wall resulting in increased biocide tolerance have already been described by McDonnell and Russell (1999) . Moreover, an increased cell-wall thickness (rather than the action of the qac genes) has been recently demonstrated to be responsible for the post-exposure resistance to acriflavine (Kawai et al. 2009 ).
The qac genes and resistance to antibiotics
A certain degree of association over time between bacterial resistance to antiseptics and antibiotics has been reported. It has been observed that some bacteria which express increased resistance to antiseptics are generally less susceptible to antibiotics. Outer membrane changes have been believed to be one of the mechanisms responsible for such increased non-specific cross-resistance (Russell 2000) . Whether the qac genes are able to directly confer resistance to antibiotics remains to be determined. Fuentes et al. (2005) recently demonstrated that qacC confers resistance to a number of β-lactam antibiotics. In addition, the nor genes, coding for resistance to fluoroquinolones, were also found to encode resistance to antiseptics and further, to have similar substrates to those of the qac genes (DeMarco et al. 2007; Theis et al. 2007 ). This indicates that resistance to antibiotics and antiseptics may closely interface (Langsrud et al. 2004 ).
Nevertheless, a close association between resistance to antiseptics and antibiotics could be primarily explained by the fact that genetic determinants of resistance to these agents are commonly linked with each other, i.e., the qac genes are typically present on plasmids together with a range of other resistance genes. For instance, the linkage between resistance to trimethoprim (dfrA), β-lactams (blaZ), aminoglycosides (aacA-aphD) and antiseptics (qacC) mediated by a multi-resistance plasmid was reported in staphylococci (Weigel et al. 2003) . In S. aureus, it is known that the qacA/B genes frequently occur on the pSK1 and β-lactamase/heavy metal-resistance plasmids which also confer resistance to a range of antibiotics (Mayer et al. 2001) . In Gram-negative bacteria, the qac genes are often linked with plasmid-mediated class 1 integrons which harbour a variety of antibiotic resistance genes (Zhao et al. 2012) . In Enterobacteriaceae, the qac genes have been most frequently found in combination with genes coding for resistance to aminoglycosides, chloramphenicol, sulphonamides, trimethoprim and β-lactams (Poirel et al. 2000; Riano et al. 2006; Espedido et al. 2008; Zhao et al. 2012) . Similar findings were also reported in Pseudomonas aeruginosa (Jeong et al. 2009; Colinon et al. 2010) . The link between the qac genes and macrolide inactivation genes was revealed in Aeromonas hydrophila (Poole et al. 2006) as well as in microflora from a wastewater treatment plant (Szczepanowski et al. 2004) . Therefore, the use of various cationic biocides may be also responsible for the selection of bacteria resistant to antibiotics (Russell 2000; Hegstad et al. 2010 ).
CONCLUSIONS
The qac genes may increase resistance to various cationic compounds and, therefore, they are of epidemiological and clinical significance. However, their specificity to particular substrates is relatively low and, compared to some antibiotic resistance genes they confer a relatively low level of resistance that can be positively or negatively affected by specific environmental conditions. It seems that the mere presence of the qac genes does not necessarily imply increased resistance to antiseptics that could be relevant for practice. Nevertheless, these genes together with other mechanisms (such as various multidrug efflux genes or modifications in the cell wall) probably contribute to the development of resistance to cationic antiseptics and survival of bacteria in toxic environments. 
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